Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
Farxiga
Pharma
ADA: Lilly's Foundayo pads case against semaglutide in diabetes
With an obesity green light already in hand, Eli Lilly is pushing for its newly launched Foundayo (orforglipron) to break into Type 2 diabetes.
Fraiser Kansteiner
Jun 8, 2026 3:42pm
Supreme Court declines to hear IRA challenges from 6 pharmas
May 18, 2026 3:06pm
AZ sets sights on 25+ blockbusters by 2030
Feb 10, 2026 11:20am
FDA takes issue with AstraZeneca TV ad for Farxiga
Nov 18, 2025 10:50am
AstraZeneca debuts DTC service with discounted Farxiga, Airsupra
Sep 26, 2025 10:51am
FDA broadens label for Bayer's Kerendia to treat heart failure
Jul 14, 2025 8:39am
